Novocure announced that Optune Lua® has received a CE (Conformité Européenne) Mark for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) concurrently with immune checkpoint inhibitors or docetaxel who have...
support patient treatment selection, we're advancing care across the oncology spectrum, solidifying our commitment to transforming cancer diagnostics and improving patient outcomes." Labcorp Plasma Detect: Advanced Risk Assessment for Colon Cancer...
capabilities. "By integrating true single cell level multi-omics data with ctDNA, OncoIncytes provides unparalleled information to oncologists that enhances critical clinical decisions," said Mohan Uttarwar, CEO and co-founder of 1Cell.Ai. "This...
drug development. “Our collaboration partner, Renova Health has used its AI and machine learning technology platform to analyze and identify optimal patient pools and study sites, enabling a swift and efficient progression of our study series over...
based on dermatologist-tested principles, integrating medical-grade phototherapy technology into a small, portable format. The goal? To make advanced fungal treatment accessible, affordable, and incredibly easy to use. Its intuitive, ergonomic...
breast cancer. To bring much-needed treatment options to patients with triple-negative breast cancer, an aggressive form of breast cancer, AstraZeneca is collaborating with Daiichi Sankyo to evaluate the potential of datopotamab deruxtecan-dlnk...
Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced the appointment of Beth Marsh as Chief Commercial Officer, effective April 28, 2025. In this role, Beth...
waiting list in the U.S., representing 86% of the national transplant list. In 2024, 27,761 kidney transplants were performed, highlighting the urgent need for innovative solutions to address the organ shortage. "This hundredth KidneyVault case is...
solid tumor patients refractory to prior treatments. The two drugs are derived from HighField’s proprietary ADCplexTM platform, containing chemotherapy payloads inhibiting Topoisomerase I and Topoisomerase II activities respectively. HF158K1 (K1)...
adoption of pharmacogenomics (PGx) in healthcare. The collaboration will focus on exploring the potential of PGx to transform healthcare delivery, aiming to enhance patient outcomes through precision medicine. PGx works by tailoring drug choice and...
B.V. (BAH). New investors Invest-NL, and the European Innovation Council (EIC) joined existing backers Oost NL and informal angels in the round. The funding accelerates the development of AMT’s ELANA® Heart Bypass System, a minimally invasive...
full Inscopix ecosystem with unique ProView Integrated 2P Lenses, the nVision behavioral acquisition unit, the IDEAS platform (including suite2p and CalmAn for specialized two-photon calcium imaging analysis), and Inscopix Data Processing Software...
and quantitation with triple-quad MS selectivity and multiple-reaction monitoring (MRM) capabilities. The ClinDART® platform also improves sustainability with a 95% reduction in solvent use, lower cost, and increased laboratory productivity....
biomedicines affordable and accessible to all patients globally, fulfilling our commitment to human health. For more information, please visit www.chimebiologics.com.
implications for improving diagnosis and treatment in oncology. Traditional methods of tissue sampling offer limited information on a tumor. Methods using 3D pathology can not only identify cases previously classified as "false negatives" but also...
using CM&S, enables precise prediction of mechanical behavior of the implants in the body, as well as provides information about degradation kinetics, tissue remodeling and interaction with the host tissue. These smart tools are reducing the need...
Fund (MRFF) Frontiers Initiative, the goal of the multidisciplinary multi-institutional investigator team is to transform the clinical management of prostate cancer by leveraging leading therapeutic radiopharmaceutical technology paired innovative...
and development activities, the Company is exploring strategic alternatives to maximize stockholder value. For more information, please visit, www.exicuretx.com.
reinvestment by TPG Asia and investment from GIC and Temasek will allow Novotech to pursue further organic growth and transformative M&A opportunities. This is part of Novotech’s ambition to become the first truly global biotech-focused CRO....
epidemiology and hospital acquired infection (HAI) tracing. Bruker has entered into a strategic collaboration for NGS bioinformatics applications in microbiology and infectious disease testing with Ridom GmbH, based in Muenster, Germany. Ridom´s...
